ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 133 filers reported holding ADMA BIOLOGICS INC in Q3 2022. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,412,124 | +10.8% | 3,187,744 | +14.3% | 0.03% | +19.2% |
| Q2 2023 | $10,295,111 | +34.0% | 2,790,003 | +20.2% | 0.03% | +18.2% |
| Q1 2023 | $7,683,698 | -17.1% | 2,321,359 | -2.8% | 0.02% | -24.1% |
| Q4 2022 | $9,267,318 | +187.6% | 2,388,484 | +80.1% | 0.03% | +163.6% |
| Q3 2022 | $3,222,000 | +189.7% | 1,325,982 | +136.2% | 0.01% | +175.0% |
| Q2 2022 | $1,112,000 | +990.2% | 561,437 | +2105.8% | 0.00% | – |
| Q4 2019 | $102,000 | -51.4% | 25,453 | -53.2% | 0.00% | -100.0% |
| Q2 2019 | $210,000 | – | 54,334 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Biomark Capital Management Co. LLC | 1,433,304 | $4,415,000 | 5.01% |
| Aisling Capital LLC | 3,608,171 | $11,113,000 | 1.83% |
| Iguana Healthcare Management, LLC | 1,130,000 | $3,480,000 | 0.96% |
| Consonance Capital Management LP | 1,273,933 | $3,924,000 | 0.43% |
| Perceptive Advisors | 1,442,204 | $4,442,000 | 0.08% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 39,000 | $120,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 11,673 | $36,000 | 0.00% |
| Renaissance Technologies | 20,300 | $63,000 | 0.00% |
| ROYAL BANK OF CANADA | 2 | $0 | 0.00% |
| VANGUARD GROUP INC | 311,514 | $960,000 | 0.00% |